Literature DB >> 23087490

On the Nature and Strategies of Organized Interests in Health Care Policy Making.

Damien Contandriopoulos1.   

Abstract

Relying on a sweeping review of the literature on interest group influence in health care policy making, we propose a basic definition and a typology of interest groups in provincial health care policy making. Then, using Milbrath's communication framework, we analyze organized interests' strategies for influencing policy making. This article is a modest attempt to cross-fertilize the group theory and resource dependency literature. This theoretical framework allows us to explore many of the recurring questions about groups' origins and strategies from an original standpoint.

Year:  2011        PMID: 23087490      PMCID: PMC3477171          DOI: 10.1177/0095399710390641

Source DB:  PubMed          Journal:  Adm Soc        ISSN: 0095-3997


  9 in total

1.  A sociological perspective on public participation in health care.

Authors:  Damien Contandriopoulos
Journal:  Soc Sci Med       Date:  2004-01       Impact factor: 4.634

2.  Unhealthy spin.

Authors:  Bob Burton; Andy Rowell
Journal:  BMJ       Date:  2003-05-31

3.  Relationships between the pharmaceutical industry and patients' organisations.

Authors:  Andrew Herxheimer
Journal:  BMJ       Date:  2003-05-31

4.  The political economy of FDA drug review: processing, politics, and lessons for policy.

Authors:  Daniel P Carpenter
Journal:  Health Aff (Millwood)       Date:  2004 Jan-Feb       Impact factor: 6.301

Review 5.  Harry and Louise go to Washington: political advertising and health care reform.

Authors:  D M West; D Heith; C Goodwin
Journal:  J Health Polit Policy Law       Date:  1996       Impact factor: 2.265

Review 6.  What information do physicians receive from pharmaceutical representatives?

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1997-05       Impact factor: 3.275

7.  Pharmaceuticals, patents, and politics: Canada and Bill C-22.

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1993       Impact factor: 1.663

8.  Who needs faster drug approval times in Canada: the public or the industry?

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1994       Impact factor: 1.663

9.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

  9 in total
  1 in total

1.  The visible politics of the privatization debate in Quebec.

Authors:  Damien Contandriopoulos; Julia Abelson; Paul Lamarche; Katia Bohémier
Journal:  Healthc Policy       Date:  2012-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.